MASH

Latest News

September 17th 2026

Ultimately, causality could not be established due to lack of data on disease severity and socioeconomic status, among others.

MASH Comorbidities May Drive Worse Transplant Outcomes

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups

MASLD, MASH Linked to Higher Mild Cognitive Impairment Risk, Lower Dementia Odds

Semaglutide More Than Doubled Likelihood of MASH Resolution

Targeting Lifestyle Factors for MASLD Management: Zobair M. Younossi, MD

a month ago

by

Brooke McCormick(+1 more)

July 18th 2026

AI phenotyping identified cardiovascular and kidney disease as key predictors of rapid fibrosis progression, complications, and higher costs in MASH.

July 3rd 2026

Real-world data show patients with MASH reach cirrhosis in just 16 months, fueling calls for wider use of fibrosis biomarkers like FIB-4.